These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 5039885

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. [Treatment of shock using pharmacological doses of corticosteroids].
    Di Carlo V, Chiesa R, Staudacher C.
    Minerva Chir; 1977 Nov 30; 32(22):1439-45. PubMed ID: 600433
    [Abstract] [Full Text] [Related]

  • 44. Vasopressin in catecholamine-resistant septic and cardiogenic shock in very-low-birthweight infants.
    Meyer S, Löffler G, Polcher T, Gottschling S, Gortner L.
    Acta Paediatr; 2006 Oct 30; 95(10):1309-12. PubMed ID: 16982509
    [Abstract] [Full Text] [Related]

  • 45. [Current concepts in physiopathology and the management of "shock"].
    De Roni EA, Navia JA, Montrul M, Invierno J, Rossi C, Esandi F, Echeverria H.
    Prensa Med Argent; 1968 May 31; 55(14):628-38. PubMed ID: 5720923
    [No Abstract] [Full Text] [Related]

  • 46. [Hemodynamic and oxyphoric aspects of septic and cardiogenic shock].
    Candiani A, Crimi G, Moschetta C, Romano R, Signore L.
    Minerva Anestesiol; 1979 May 31; 45(7-8):536-56. PubMed ID: 548816
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Calcium antagonists in shock--a minireview of the evidence.
    Parratt JR.
    Prog Clin Biol Res; 1989 May 31; 308():1065-74. PubMed ID: 2675039
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Pharmacologic support in cardiogenic shock.
    Rude RE.
    Adv Shock Res; 1983 May 31; 10():35-49. PubMed ID: 6349299
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. [Current status of the treatment of infectious shock].
    Rapin M.
    Anesth Analg (Paris); 1969 May 31; 26(5):753-62. PubMed ID: 5368578
    [No Abstract] [Full Text] [Related]

  • 55. Protective effects of nylidrin and isoproterenol against hemorrhagic shock.
    Grega GJ, Kinnard WJ.
    J Pharmacol Exp Ther; 1968 May 31; 161(1):98-110. PubMed ID: 5648505
    [No Abstract] [Full Text] [Related]

  • 56. [Current aspects of enzyme-inhibitory therapy].
    Stoimenov G, Doĭchinov Al.
    Akush Ginekol (Sofiia); 1971 May 31; 10(1):86-7. PubMed ID: 5316428
    [No Abstract] [Full Text] [Related]

  • 57. Shock: the hemodynamic diagnosis and treatment.
    Eastridge CE, Hughes FA.
    South Med J; 1969 Jun 31; 62(6):665-70. PubMed ID: 5786650
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.